Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Free Cash Flow (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Free Cash Flow data on record, last reported at -$1.7 million in Q4 2025.

  • For Q4 2025, Free Cash Flow fell 504.95% year-over-year to -$1.7 million; the TTM value through Oct 2025 reached $5.8 million, up 396.48%, while the annual FY2025 figure was $7.0 million, 214.01% up from the prior year.
  • Free Cash Flow reached -$1.7 million in Q4 2025 per CSBR's latest filing, down from $554000.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $6.9 million in Q2 2025 and bottomed at -$4.7 million in Q3 2023.
  • Average Free Cash Flow over 5 years is $1450.0, with a median of -$110500.0 recorded in 2024.
  • Peak YoY movement for Free Cash Flow: crashed 2000.0% in 2021, then soared 806.96% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $662000.0 in 2021, then soared by 305.14% to $2.7 million in 2022, then plummeted by 80.98% to $510000.0 in 2023, then tumbled by 155.49% to -$283000.0 in 2024, then crashed by 504.95% to -$1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$1.7 million in Q4 2025, $554000.0 in Q3 2025, and $6.9 million in Q2 2025.